- Home
- TIC vs CPRX Comparison
TIC vs CPRX Comparison
Compare TIC & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIC
- CPRX
- Stock Information
- Founded
- TIC 1991
- CPRX 2002
- Country
- TIC United States
- CPRX United States
- Employees
- TIC N/A
- CPRX N/A
- Industry
- TIC
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- TIC
- CPRX Health Care
- Exchange
- TIC Nasdaq
- CPRX Nasdaq
- Market Cap
- TIC 2.3B
- CPRX 2.6B
- IPO Year
- TIC N/A
- CPRX 2006
- Fundamental
- Price
- TIC $11.39
- CPRX $19.97
- Analyst Decision
- TIC Buy
- CPRX Strong Buy
- Analyst Count
- TIC 2
- CPRX 5
- Target Price
- TIC $13.50
- CPRX $33.20
- AVG Volume (30 Days)
- TIC 1.7M
- CPRX 1.5M
- Earning Date
- TIC 11-03-2025
- CPRX 11-05-2025
- Dividend Yield
- TIC N/A
- CPRX N/A
- EPS Growth
- TIC N/A
- CPRX 183.96
- EPS
- TIC N/A
- CPRX 1.65
- Revenue
- TIC $1,113,179,000.00
- CPRX $558,499,000.00
- Revenue This Year
- TIC $30.22
- CPRX $16.51
- Revenue Next Year
- TIC $33.38
- CPRX $9.58
- P/E Ratio
- TIC N/A
- CPRX $12.14
- Revenue Growth
- TIC 4.23
- CPRX 28.55
- 52 Week Low
- TIC $8.76
- CPRX $19.15
- 52 Week High
- TIC $14.28
- CPRX $26.58
- Technical
- Relative Strength Index (RSI)
- TIC N/A
- CPRX 45.00
- Support Level
- TIC N/A
- CPRX $19.60
- Resistance Level
- TIC N/A
- CPRX $20.75
- Average True Range (ATR)
- TIC 0.00
- CPRX 0.76
- MACD
- TIC 0.00
- CPRX 0.02
- Stochastic Oscillator
- TIC 0.00
- CPRX 30.19
About TIC Acuren Corporation Common Stock
Acuren Corp operates as a provider of critical asset integrity services. The company provides testing, inspection, engineering and lab testing services in different industrial markets such as chemical, pipeline, refinery, power generation, oilsands, automotive, aerospace, mining, manufacturing, renewable energy, and pulp and paper. The company's service line includes Nondestructive Testing (NDT) techniques such as radiography, ultrasonic testing, magnetic particle inspection, penetrant testing, etc., Rope Access Technician Solutions (RAT), and Engineering and Lab Testing. The company has two operating and reportable segments, which are the United States, generating maximum revenue, and Canada.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).